Metformin effectively reduce viral load in COVID-19 patients, finds study
A recent study published in the Clinical Infectious Diseases journal uncovered the potential of metformin which is commonly used to treat type 2 diabetes to manage COVID-19. This research was conducted as part of the COVID-OUT trial and unveiled strong evidence of antiviral activity of metformin against the RNA viruses, including the SARS-CoV-2.
This comprehensive highlights that metformin exerts its antiviral effects by targeting the host mechanistic target of rapamycin pathway which in turn suppresses the protein translation that is crucial for viral replication. The implications of this mechanism extend beyond diabetes management which could offer a new avenue for tackling infectious diseases.
This rigorous randomized, placebo-controlled, double-blind COVID-OUT trial evaluated the efficacy of metformin along with other potential treatments for COVID-19, including fluvoxamine and ivermectin. The results were striking: metformin demonstrated remarkable effectiveness in reducing the odds of hospitalizations, deaths, and even the onset of long COVID.
The participants who received metformin underwent a sharp 58% reduction in the risk of hospitalizations or death within 28 days. Also, the medication decreased the likelihood of emergency department visits, hospitalizations or death by 42% within 14 days and reduced the incidence of long COVID by 42% over a span of 10 months.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.